VUSI yields 1.44% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, VUSI + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VUSI + MRK for your $10,000?
VUSI is an actively managed ETF, designed to provide high levels of current income consistent with preservation of capital. It invests in a diversified mix of income-producing bonds and similar instruments, including both US and international, including emerging markets, issuers. Holdings include government and corporate bonds, asset- and mortgage-backed securities, loans, and derivatives. The funds average portfolio duration is kept to no more than one year, making it less sensitive to interest rate fluctuations. The fund primarily invests in investment-grade debt but may allocate up to 15% to high-yield securities. It also utilizes derivatives such as swaps, options, and futures, for hedging, enhancing returns, and effective cash management. The management team employs an investment process combining macroeconomic views with detailed fundamental analysis and risk management, supported by proprietary research and scenario-based analytics.
Full VUSI Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.